The landscape of managing diabetes is advancing with the introduction of transdermal GLP-1 delivery . These innovative devices offer a potentially less invasive alternative to shots for individuals living with diabetes 2. They deliver a GLP-1 agonist directly through the epidermis, avoiding the n